Solid Biosciences Inc. (SLDB) Social Stream



Solid Biosciences Inc. (SLDB): $8.51

0.61 (-6.69%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add SLDB to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#199 of 360

in industry

SOLID BIOSCIENCES INC (SLDB) Price Targets From Analysts

Use the tables below to see what analysts covering SOLID BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 6 $17 $5.5 $10.3 $5.76 78.82%
2022-03-14 5 $17 $5.5 $10.3 $5.76 78.82%
2022-03-15 4 $17 $5 $10.2 $5.76 77.08%
2022-04-28 5 $17 $5 $9.4 $5.76 63.19%
2022-05-18 4 $12 $2 $6.5 $5.76 12.85%
2022-08-11 5 $12 $2 $6.5 $5.76 12.85%
2022-08-15 5 $12 $2 $6.25 $5.76 8.51%
2022-10-03 5 $12 $1 $6 $5.76 4.17%
2022-10-18 5 $6 $1 $3.25 $5.76 -43.58%
2022-11-11 6 $89.955 $6 $37.383 $5.76 549.01%
2023-01-13 6 $89.955 $6 $32.152 $5.76 458.19%
2023-05-12 6 $89.955 $6 $23.591 $5.76 309.57%
2023-06-23 5 $89.955 $6 $23.791 $5.76 313.04%
2023-08-16 4 $8 $6 $7.25 $5.76 25.87%
2023-09-10 6 $8 $6 $7 $5.76 21.53%
2023-09-22 6 $8 $5 $6.666 $5.76 15.73%
2023-11-09 6 $8 $5 $6.666 $5.76 15.73%
2023-11-23 7 $8 $5 $6.25 $5.76 8.51%
2023-12-08 8 $9 $5 $6.8 $5.76 18.06%

The Trend in the Analyst Price Target


SLDB's average price target has moved down $3.5 over the prior 21 months.

Over the past 47 weeks, SLDB's average upside potential has been 231.77%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-06-23 5 89.955 6 23.791 5.49 333.35%
2023-08-14 4 8.000 6 7.250 3.85 88.31%
2023-08-16 5 8.000 6 7.250 3.76 92.82%
2023-09-22 6 8.000 5 6.666 2.76 141.52%
2023-11-09 6 8.000 5 6.666 2.13 212.96%

SLDB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 4 0 4 0 0 8

The Trend in the Broker Recommendations


Over the past 16 months, SLDB's average broker recommendation rating improved by 0.2.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, SOLID BIOSCIENCES INC's average analyst price target is higher than 410.49% of them.
  • SOLID BIOSCIENCES INC's variance in analysts' estimates is lower than -2122.48% of all US stocks.
  • SOLID BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 1033.81% of Pharmaceutical Products stocks.
  • In terms of how SOLID BIOSCIENCES INC fares relative to Healthcare stocks, note that its number of analysts covering the stock is greater than 827.95% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to SOLID BIOSCIENCES INC are XFOR, APTO, and OTLK.

Is SLDB a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!